Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure.
Publication/Presentation Date
7-1-1981
Abstract
Although the effect of systemic vasodilator therapy on left ventricular function in congestive heart failure has been extensively evaluated, little is known about its effect on pulmonary vascular resistance and right ventricular function. Since pulmonary vascular resistance is mediated in part by alpha-adrenergic receptors, we studied the effects of the alpha-adrenergic antagonist prazosin on right ventricular function as determined by a radionuclide ventriculographic technique which assessed right and left ventricular ejection fractions simultaneously. In 11 patients treated for two months with prazosin, right ventricular ejection fraction increased from 0.28 +/- 0.04 to 0.44 +/- 0.07 (p less than 0.01). In 10 patients who received a single dose of prazosin 48 hours after withdrawal of prior prazosin therapy, right ventricular ejection fraction increased from 0.29 to 0.05 to 0.38 +/- 0.06 (p less than 0.02). In nine patients who received a single dose of prazosin during right sided heart catheterization, pulmonary vascular resistance decreased from 358 +/- 70 to 236 +/- 60 dyne-sec-cm -5 (p less than 0.01). These studies suggest that prazosin has beneficial effects on right ventricular function both immediately and long-term in patients with severe congestive heart failure. Although the mechanism of this effect is not known, possibilities include a direct effect of prazosin on the pulmonary vasculature, a secondary reduction in right ventricular afterload due to improved left ventricular performance and a withdrawal of reflex-mediated pulmonary vasoconstriction due to improved left ventricular performance.
Volume
71
Issue
1
First Page
75
Last Page
80
ISSN
0002-9343
Published In/Presented At
Colucci, W. S., Holman, B. L., Wynne, J., Carabello, B., Malacoff, R., Grossman, W., & Braunwald, E. (1981). Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure. The American journal of medicine, 71(1), 75–80. https://doi.org/10.1016/0002-9343(81)90261-8
Disciplines
Medicine and Health Sciences
PubMedID
6113759
Department(s)
Department of Medicine
Document Type
Article